NeuroPace Inc (NPCE)
13.76
-0.24
(-1.71%)
USD |
NASDAQ |
Apr 17, 16:00
13.76
0.00 (0.00%)
After-Hours: 20:00
NeuroPace Cash from Investing (TTM): 23.03M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 23.03M |
| September 30, 2023 | 28.46M |
| June 30, 2023 | 31.24M |
| March 31, 2023 | 34.17M |
| December 31, 2022 | 23.80M |
| September 30, 2022 | 14.74M |
| June 30, 2022 | 7.586M |
| Date | Value |
|---|---|
| March 31, 2022 | -80.67M |
| December 31, 2021 | -85.40M |
| September 30, 2021 | -95.29M |
| June 30, 2021 | -95.35M |
| March 31, 2021 | -15.33M |
| December 31, 2020 | -10.77M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-95.35M
Minimum
Jun 2021
34.17M
Maximum
Mar 2023
-16.91M
Average
7.586M
Median
Jun 2022
Cash from Investing (TTM) Benchmarks
| Ainos Inc | -0.1015M |
| OpGen Inc | -1.204M |
| Zomedica Corp | 1.577M |
| LENSAR Inc | -4.156M |
| Eargo Inc (DELISTED) | -0.548M |